Please login to the form below

Not currently logged in
Email:
Password:

Changes to Merck's executive board

Merck has appointed Dr Stefan Oschmann as head of its pharmaceuticals business sector and Dr Kai Beckmann as a member of the executive board

Merck has announced that Dr Stefan Oschmann will become a member of the executive board and general partner following Elmar Schnee's departure from the company for personal reasons.

In line with the duties of his predecessor, Dr Oschmann will be responsible for both Merck Serono and Consumer Health Care, and will assume the lead of the Merck Serono division as of January 1, 2011.

Born in Würzburg, Germany in 1957, Dr Oschmann obtained a degree in veterinary medicine and a PhD at the University of Munich. After working for a period of time at the International Atomic Energy Agency, he joined the American company Merck & Co (outside North America: MSD – Merck Sharp & Dohme) in 1989, where he held various positions in Belgium, the Netherlands and Austria.

He was appointed vice president of Central and Eastern Europe in 1998 and vice president of Europe in 1999, and was also in charge of the German business of Merck & Co until 2005, when he moved to the headquarters of Merck & Co as senior vice president in charge of Worldwide Human Health Marketing. In 2006 he became a member of the senior management and corporate officer in charge of Europe, the Middle East, Africa and Canada, and since 2009 has served as President of emerging markets for Merck & Co. 

Merck also announced that Dr Kai Beckmann is to become a member of the executive board and general partner of Merck, effective April 1, 2011, responsible for the newly-created executive board position of human resources.

Dr Kai Beckmann was born in Hanau, Germany in 1965 and studied computer science at the Technical University of Darmstadt. He began his career at Merck in 1989 as an IT consultant. After obtaining a doctorate in economics he held several leading positions in IT and was appointed managing director of the Merck subsidiary in Singapore and Malaysia in 2004. In early 2007 he returned to Germany to become chief information officer of Merck.

15th December 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics